­CAPhO Conference 2026

Submit an Abstract

Submit an Abstract

Click on the links below to go directly to any of the following sections:

How to Write an Abstract

Are you ready to submit your work and want some guidance on how to write an abstract? CAPhO offers members a webinar recording titled “How to Create an Academic Poster” providing ‘tips and tricks’ you may wish to reference, however, please follow the guidelines provided on this page for submitting your abstract. Log in as a member to access the recording. Not a member? Join here.  

Submit your Abstract(s)

Submit your abstract via CAPhO's online submission site by Monday, January 26, 2026 at 23:59 PST. The submitting author will be notified of acceptance by email the week of February 16, 2026. 

Click here to submit your abstract 

Abstract Submission Guidelines

Key Dates

  • Abstract submission deadline: Monday, January 26, 2026, 23:59 PSDT.
  • Acceptance notification to the submitting author via email: Week of February 16, 2026
  • Presenting Author Registration Deadline: Wednesday, February 25, 2026
  • Electronic version of Poster submission deadline (applies to all accepted abstracts): Wednesday, March 18, 2026

Presenting Author Registration

The presenting author of an accepted abstract MUST register for the Conference by Wednesday, February 25, 2026, or the abstract will automatically be withdrawn. The submitting author is responsible for notifying the presenting author of the registration deadline. 

Publication

All accepted abstracts will be published (online only) in a supplement of the Journal of Oncology Pharmacy Practice (JOPP) in 2026 (issue # TBD), provided the presenting author registers for the Conference by Wednesday, February 25, 2026. By submitting an abstract, you consent to the publication of this abstract in JOPP and on the CAPhO website.

Conflict of Interest Disclosure, Artificial Intelligence (AI) Use and Sponsor Information

During the abstract submission process, you will be asked to disclose any conflicts of interest and indicate whether artificial intelligence (AI) tools were used in developing your abstract. If applicable, please also provide the name and contact information (including phone and email) of the abstract sponsor.

Author Information

The following author information is required:

  • Name, contact information and affiliation of submitting author
  • Name, contact information and affiliation of any co-authors, including presenting author
Posters

Presentation Types

The following two presentation types are available:

  • New Poster (poster that has not been displayed before)
  • Encore Poster (poster that has been presented elsewhere)

Only new posters submitted by CAPhO members are considered for the CAPhO Poster Awards. Encore posters are not considered for judging, however, may be presented to provide exposure to a new audience.

Title and Content

The abstract title must be less than 200 characters. Please use title case e.g. Upper and Lower Case and NOT UPPER CASE.

The submission system will prompt you to follow the following abstract format:

  • Introduction / Objectives
  • Study Design / Methods
  • Results / Key Findings
  • Discussion
  • Conclusion / Recommendations
  • References (include up to 5, if applicable)
  • Sources of Funding

Note: Abstracts must describe completed research or project work (i.e. contain results and conclusions) and can include up to 5 references.

Submission Categories

The following four submission categories are available:

  • Administration: Staff training programs, pharmacoeconomics, drug preparation and delivery, projects that address compliance to provincial regulatory standards or national best practice guidelines
  • Pharmacy practice (non-research based): Descriptions of innovative patient care programs, drug utilization evaluations/drug management programs, quality assurance projects
  • Research - Clinical: Evaluation of pharmacist interventions, clinical qualitative studies, meta-analyses or scoping reviews on clinical topics
  • Research - Non-clinical: Original research on drug stability, pharmacokinetic studies, pharmacodynamics studies including incidence of adverse reactions, pharmacogenomics projects, patient attitude or behavioral studies, education projects

Abstract Length

Posters 2

The maximum length of an abstract is 500 words.

Abbreviations

The use of standard abbreviations is desirable.

Language

Abstracts and posters are accepted in either English or French.

Number of Submissions

An individual may submit up to two abstracts as primary author. There is no limit on the number of abstracts that an individual can co-author.

Poster Display Details

Poster Specifications

  • All new posters are not to exceed 46 inches x 46 inches in dimension. There will be two posters per board surface. If your poster exceeds the size limit, it may be removed.
  • Encore posters that exceed 46 inches x 46 inches size must be pre-approved by the Conference Organizers, and in which case, please email abstract@capho.org to advise of your poster size.
  • All posters must be displayed on poster material. Sheets paper glued together, or the like will not be accepted.
  • Materials must be readable from a distance of 3 feet or more.
  • The font used must be a minimum of 20 points.
  • Industry-sponsored posters must clearly be identified as such - please state on your poster "Sponsored by (Company name/s)".
  • Optional: Include QR code for a 5 – 7-minute narrated presentation about your poster.

PDF Poster

An electronic version of the poster is required to be sent to abstract@capho.org by Wednesday, March 18, 2026 for pre-Conference judging and posting on the Conference app and online platform. All accepted posters will be available for viewing from April 23 to 26, 2026 and post-Conference for a limited time.

CAPhO Poster Awards

Posters will be judged virtually by the CAPhO Research Committee prior to the Conference. 

Awards 2

In order to be eligible for one of four CAPhO Poster Awards in the categories outlined above, the submitting author must have paid their CAPhO membership fee by February 1, 2026. Encore posters, posters submitted by non-CAPhO members and company sponsored posters are not considered for the CAPhO Poster Awards.

Poster Award recipients will be announced prior to the Conference and are required to deliver a live 5-minute presentation at the CAPhO Poster Award Presentation Session, tentatively scheduled for Sunday, April 26, 2026, from 10:05 to 10:35. 

NEW for 2026: CAPhO Participants’ Choice Award
The CAPhO Participants’ Choice Award will go to the poster that receives the highest number of votes from participants during the Conference. There is no live presentation for this award.

Abstract Submission Terms and Conditions

  • An individual may submit up to two abstracts as primary author. There is no limit on the number of abstracts that an individual can co-author.
  • All submissions will be kept by the CAPhO Conference organizers and will not be returned.
  • All submissions are subject to review by the CAPhO Research Committee.
  • The CAPhO Research Committee reserves the right to decline any abstract for any reason.
  • Submitting authors will be notified of the CAPhO Research Committee's decision(s) by email the week of February 16, 2026. 
  • The presenting author must register for CAPhO 2026 by Wednesday, February 25, 2026. 
  • The presenting author must bring a hard copy version of the poster to the Conference following the specific details on hard copy poster presentations in the guidelines as well as submit an electronic version. The electronic version must be sent to abstract@capho.org by Wednesday, March 18, 2026 for pre-Conference judging and for posting on the online platform and Conference App.
  • All accepted posters will be posted on the CAPhO website and Conference online platform and will be available for viewing from April 23 to 26, 2026 during the Conference and post-Conference for a limited time.
  • A panel of judges will review all new posters of CAPhO members prior to the Conference. If the presenting author meets the eligibility criteria and opts to have the poster considered for the Poster Award during the poster submission process, and the poster is selected, the author will be asked to give a brief live presentation during the Conference. More details to follow.
  • By submitting an abstract to CAPhO Conference 2026 the authors give consent to have their abstract published in the supplement of the Journal of Oncology Pharmacy Practice in 2026. Issue # TBD. 
  • Authors agree to declare any conflicts of interest and/or issues concerning copyright during the submission process.  

Questions

If you have any questions regarding the submission system, contact us at abstract@capho.org.

If you have any questions regarding scientific content, contact Laura Minard, CAPhO Research Committee Chair, by email at research@capho.org.